Richard Bucala
- Clinical Biochemistry top 0.1%
- Molecular Biology top 10%
- Endocrinology, Diabetes and Metabolism top 2%
- Physiology top 5%
- Cancer Research top 10%
- Co-authors
- Anthony CeramiZenji MakitaHelen VlassaraYousef Al‐AbedPeter ModelAndrew T. PapoulisJason ChesneyPeter Ulrich
- Topics
- Advanced Glycation End Products research (14 papers)Natural Antidiabetic Agents Studies (4 papers)Glycosylation and Glycoproteins Research (3 papers)
- Partner nations
- United StatesJapanGermany
In The Last Decade
Richard Bucala
21 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 115
- Clinical Biochemistry 1.3k
- Molecular Biology 728
- Endocrinology, Diabetes and Metabolism 728
- Physiology 384
- Cancer Research 264
Countries citing papers authored by Richard Bucala
This map shows the geographic impact of Richard Bucala's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Bucala with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Bucala more than expected).
Fields of papers citing papers by Richard Bucala
This network shows the impact of papers produced by Richard Bucala. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Bucala. The network helps show where Richard Bucala may publish in the future.
Co-authorship network of co-authors of Richard Bucala
This figure shows the co-authorship network connecting the top 25 collaborators of Richard Bucala. A scholar is included among the top collaborators of Richard Bucala based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Bucala. Richard Bucala is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 76 | |
| 2 | 63 | |
| 3 | 2 | |
| 4 | 14 | |
| 5 | 236 | |
| 6 | 7 | |
| 7 | 28 | |
| 8 | 27 | |
| 9 | 35 | |
| 10 | 385 | |
| 11 | 17 | |
| 12 | 48 | |
| 13 | 138 | |
| 14 | 42 | |
| 15 | 439 | |
| 16 | 442 | |
| 17 | 13 | |
| 18 | 36 | |
| 19 | 31 | |
| 20 | 170 |
About Richard Bucala
Richard Bucala is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Cancer Research, having authored 21 papers that have together received 2.3k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (14 papers), Natural Antidiabetic Agents Studies (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Clinical Biochemistry (1.3k citations), Endocrinology, Diabetes and Metabolism (728 citations) and Nephrology (172 citations). Richard Bucala has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Anthony Cerami, Zenji Makita, Helen Vlassara, Yousef Al‐Abed, Peter Model, Andrew T. Papoulis, Jason Chesney, Peter Ulrich, Anthony Cerami and Xin Zhang. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.